C. Marenghi
University of Milan
PsychiatryCancerInternal medicineRadiologyUrologySurgeryOncologyOdds ratioIntensive care medicinePhysical therapyQualitative researchBiopsyChemotherapyNeutropeniaPTENTolerabilityDiseaseQuality of life (healthcare)Prostate cancerProtocol (science)PopulationGynecologyIn patientVery low riskRe biopsyHealth related quality of lifeRepeat biopsyDoubling timeFamily medicineBreast cancerAnxietyGeneral surgeryClinical psychologyMedicineCohortCoping (psychology)
43Publications
6H-index
201Citations
Publications 43
Newest
#1Paolo GandelliniH-Index: 25
Last. Nadia ZaffaroniH-Index: 66
view all 16 authors...
Active surveillance (AS) has evolved as a strategy alternative to radical treatments for very low risk and low-risk prostate cancer (PCa). However, current criteria for selecting AS patients are still suboptimal. Here, we performed an unprecedented analysis of the circulating miRNome to investigate whether specific miRNAs associated with disease reclassification can provide risk refinement to standard clinicopathological features for improving patient selection. The global miRNA expression profi...
Source
#1Paolo GandelliniH-Index: 25
#2Nicola Casiraghi (University of Trento)H-Index: 7
Last. Nadia ZaffaroniH-Index: 66
view all 11 authors...
Source
#1Paola DordoniH-Index: 6
#1Paola DordoniH-Index: 2
Last. Lara BellarditaH-Index: 10
view all 11 authors...
OBJECTIVE: To investigate whether prostate cancer (PCa) patients' coping strategies (i.e., fighting spirit, anxious preoccupation, fatalism, helplessness/hopelessness, and avoidance) significantly change during the first 3-year follow-up period of active surveillance (AS). MATERIALS AND METHODS: Altogether, 104 patients on AS completed the Mini-Mental Adjustment to Cancer (Mini-MAC) at baseline (T0), at 10 and 12 months after diagnostic biopsy (T1 and T2, respectively) and then at 24- (T3) and 3...
2 CitationsSource
Background The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination]. Even if it is known from the literature that the majority of PCa men in AS do not report heightened anxiety, there is a minority of patients who show clinically significan...
Source
#1M. RoscignoH-Index: 5
#1M. RoscignoH-Index: 4
view all 31 authors...
Source
#1F. BadenchiniH-Index: 3
#2C. MarenghiH-Index: 6
Last. Nicola NicolaiH-Index: 28
view all 25 authors...
Source
#1F. BadenchiniH-Index: 3
#2C. MarenghiH-Index: 6
Last. Nicola NicolaiH-Index: 28
view all 25 authors...
Source
#1Julia Menichetti (University of Oslo)H-Index: 9
#2Letizia De LucaH-Index: 2
Last. Lara BellarditaH-Index: 10
view all 7 authors...
OBJECTIVE: Health promotion is a key aspect for health outcomes of prostate cancer (PCa) patients. However, it has been poorly explored among patients following monitoring programmes, for example Active Surveillance (AS). This study aimed to explore PCa patients' perceptions of health promotion during AS. METHODS: An explorative qualitative research design was adopted. Four focus groups were used to collected data from 24 men enrolled in the Prostate Cancer Research International: AS (PRIAS) pro...
1 CitationsSource
#1Paolo GandelliniH-Index: 25
#2Nicola Casiraghi (University of Trento)H-Index: 7
Last. Nadia ZaffaroniH-Index: 66
view all 11 authors...
Abstract Background Genomic characterization of prostate cancer (PCa) biopsies may improve criteria for the selection of patients suitable for active surveillance (AS). Objective To identify somatic genomic aberrations associated with adverse outcome as AS protocol exclusion indicators. Design, setting and participants Whole-exome sequencing profiles were generated for Gleason score (GS) = 3 + 3 biopsies obtained from 54 PCa patients enrolled in two AS protocols. Patients were selected as repres...
1 CitationsSource
#1Nicola NicolaiH-Index: 28
#2F. BadenchiniH-Index: 3
Last. R. ValdagniH-Index: 4
view all 20 authors...
Source